Recent advances in targeted therapies in acute myeloid leukemia

RS Bhansali, KW Pratz, C Lai - Journal of Hematology & Oncology, 2023 - Springer
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. While survival
for younger patients over the last several decades has improved nearly sixfold with the …

Genetic basis and molecular profiling in myeloproliferative neoplasms

D Luque Paz, R Kralovics, RC Skoda - Blood, 2023 - ashpublications.org
Abstract BCR:: ABL1-negative myeloproliferative neoplasms (MPNs) are clonal diseases
originating from a single hematopoietic stem cell that cause excessive production of mature …

Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia

B Falini, MP Martelli - American Journal of Hematology, 2023 - Wiley Online Library
Several editions of the World Health Organization (WHO) classifications of lympho‐
hemopoietic neoplasms in 2001, 2008, and 2016 served as the international standard for …

[HTML][HTML] Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated Acute Myeloid Leukemia (AML) to guide treatment strategy

M Ruglioni, S Crucitta, GI Luculli, G Tancredi… - Critical Reviews in …, 2024 - Elsevier
The presence of FLT3 mutations, including the most common FLT3-ITD (internal tandem
duplications) and FLT3-TKD (tyrosine kinase domain), is associated with an unfavorable …

Hereditary platelet disorders associated with germ line variants in RUNX1, ETV6, and ANKRD26

CC Homan, HS Scott, AL Brown - Blood, 2023 - ashpublications.org
Hereditary platelet disorders (HPDs) are a group of blood disorders with variable severity
and clinical impact. Although phenotypically there is much overlap, known genetic causes …

Molecular taxonomy of myelodysplastic syndromes and its clinical implications

E Bernard, RP Hasserjian, PL Greenberg… - Blood, 2024 - ashpublications.org
Myelodysplastic syndromes (MDS) are clonal hematologic disorders characterized by
morphologic abnormalities of myeloid cells and peripheral cytopenias. Although genetic …

Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS …

JP Bewersdorf, Z Xie, R Bejar, U Borate, J Boultwood… - Blood Reviews, 2023 - Elsevier
Biological events that contribute to the pathogenesis of myelodysplastic
syndromes/neoplasms (MDS) are becoming increasingly characterized and are being …

Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf …

C Gurnari, M Robin, LA Godley… - The Lancet …, 2023 - thelancet.com
The recent application of whole exome or whole genome sequencing unveiled a plethora of
germline variants predisposing to myeloid disorders, particularly myelodysplastic …

Clonal dynamics and copy number variants by single‐cell analysis in leukemic evolution of myeloproliferative neoplasms

L Calabresi, C Carretta, S Romagnoli… - American Journal of …, 2023 - Wiley Online Library
Transformation from chronic (CP) to blast phase (BP) in myeloproliferative neoplasm (MPN)
remains poorly characterized, and no specific mutation pattern has been highlighted. BP …

Advances in the classification of myeloid and lymphoid neoplasms

DA Arber, E Campo, ES Jaffe - Virchows Archiv, 2023 - Springer
The diagnosis, classification and treatment of hematopoietic neoplasms requires a precise
definition of the individual entities that configure the broad spectrum of these diseases …